What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Disease
Steven J. Collins mostly deals with Disease, Retinoic acid, Retinoic acid receptor, Pathology and Cancer research.
Steven J. Collins is interested in Acute promyelocytic leukemia, which is a branch of Retinoic acid.
His Acute promyelocytic leukemia study integrates concerns from other disciplines, such as Leukemia and Mutant.
In his work, Cellular differentiation, Receptor, Tretinoin, Proteomics and RNA is strongly intertwined with Cell biology, which is a subfield of Retinoic acid receptor.
Steven J. Collins has included themes like Myeloid, Immunology and Promyelocyte in his Cellular differentiation study.
His Pathology research focuses on Central nervous system disease and how it relates to Magnetic resonance imaging, Fluid-attenuated inversion recovery and Electroencephalography.
His most cited work include:
- Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. (1387 citations)
- The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression (1074 citations)
- Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia (817 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Disease, Pathology, Biochemistry, Cell biology and Retinoic acid.
His study in Disease is interdisciplinary in nature, drawing from both Pediatrics and Virology.
As part of his studies on Pathology, he often connects relevant areas like Immunology.
Steven J. Collins combines topics linked to Receptor with his work on Cell biology.
Steven J. Collins interconnects Cancer research and Cellular differentiation in the investigation of issues within Retinoic acid.
His study looks at the relationship between Cellular differentiation and topics such as Cell culture, which overlap with Molecular biology.
He most often published in these fields:
- Disease (34.22%)
- Pathology (24.58%)
- Biochemistry (15.28%)
What were the highlights of his more recent work (between 2017-2021)?
- Disease (34.22%)
- Cerebrospinal fluid (13.62%)
- Internal medicine (13.95%)
In recent papers he was focusing on the following fields of study:
Steven J. Collins mainly focuses on Disease, Cerebrospinal fluid, Internal medicine, Biomarker and Alzheimer's disease.
To a larger extent, he studies Pathology with the aim of understanding Disease.
His study explores the link between Cerebrospinal fluid and topics such as Csf biomarkers that cross with problems in β amyloid.
His Internal medicine research includes themes of Endocrinology and Oncology.
His Biomarker study combines topics in areas such as Clinical endpoint, Neurodegeneration and Bioinformatics.
The Alzheimer's disease study combines topics in areas such as Neuropathology and Dementia, Frontotemporal dementia, Cognitive decline.
Between 2017 and 2021, his most popular works were:
- Iatrogenic Creutzfeldt-Jakob disease with Amyloid-β pathology: an international study. (44 citations)
- ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes (31 citations)
- Age at onset in genetic prion disease and the design of preventive clinical trials. (28 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Disease
His primary areas of investigation include Alzheimer's disease, Biomarker, Cerebrospinal fluid, PRNP and Pathology.
His Biomarker study combines topics from a wide range of disciplines, such as Neurodegeneration, Oncology and Cognitive decline.
Steven J. Collins usually deals with Cerebrospinal fluid and limits it to topics linked to Dementia and Schizophrenia, C-reactive protein and Bioinformatics.
His research integrates issues of Cell, Cancer research, Cell culture and Plasma protein binding in his study of PRNP.
His work in the fields of Pathology, such as Amyloid, Amyloid beta and PrPSc Proteins, intersects with other areas such as Angiopathy.
Steven J. Collins has researched Disease in several fields, including Penetrance, Asymptomatic and Surrogate endpoint.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
